Business: Azenta is a life sciences company that operates through two segments. First, there's the life sciences products division, which offers automated cold sample management systems for compound ...

2025 was another turbulent year for Azenta AZTA stock, which fell more than 30% as the medical solutions provider struggled with ongoing sales weakness. Azenta’s struggles have been highlighted by ...

Azenta, Inc. is a Massachusetts headquartered company that is focused on the development and marketing of comprehensive biological and chemical compound sample management and genomic solutions. These ...

Azenta (NASDAQ:AZTA) is preparing to release its quarterly earnings on Tuesday, 2024-11-12. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

Azenta Life Sciences, a key player in the life sciences industry, is poised for financial recovery with a robust Q2 performance and cost-cutting measures, making it an enticing investment opportunity.

Azenta (NASDAQ:AZTA) will release its quarterly earnings report on Friday, 2025-11-21. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Azenta to report an earnings ...

Azenta, Inc. ((AZTA)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with ...

BURLINGTON, Mass. - Azenta, Inc. (NASDAQ:AZTA) announced Monday that its affiliate, Azenta Germany GmbH, has signed a binding agreement to sell its B Medical Systems business to THELEMA S.À R.L. for ...